-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research-2012.pdf
January 01, 2012 - patient data systematic review
of inhaled budesonide among participants with chronic obstructive pulmonary … One example is exercise therapy
32
for patients with chronic obstructive pulmonary disease. … For example, phosphodiesterase-4 inhibitors are new drugs for
patients with chronic obstructive pulmonary … Pulmonary rehabilitation for chronic obstructive
pulmonary disease. … Phosphodiesterase 4 inhibitors for chronic
obstructive pulmonary disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
July 01, 2012 - use may also explain its limited use in conditions other than in patients
with chronic obstructive pulmonary … disease (COPD) and acute
cardiogenic pulmonary edema (ACPE). … comparing CPAP and BPAP
have been addressed repeatedly in previous literature (mainly for
cardiogenic pulmonary … Peer Reviewer 4 Methods 5) I don't think the various potential indications for NIV (COPD, pulmonary … COPD, pulmonary
edema, etc) either in a trial-level meta-regression or a stratified analysis?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-cough_research-protocol.pdf
October 22, 2012 - Such chronic cough is responsible for up to 38 percent of pulmonary outpatient visits.2,3
Although … This review,
mainly in patients with asthma and chronic obstructive pulmonary disease, found that cough … Underlying etiologies (asthma, GERD, upper airway cough syndrome, tobacco
use, ACE inhibitor use, pulmonary … Underlying etiologies
• Asthma
• GERD
• Upper airway cough
syndrome
• Tobacco use
• ACE inhibitor user
• Pulmonary … Underlying etiologies (asthma, GERD, upper
airway cough syndrome, tobacco use, ACE
inhibitor use, pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
January 24, 2022 - (75)*
IC: 9* (56.3)*
SOT
Diabetes: 11 (39.3)
Arterial hypertension: 19 (67.9)
Obesity: 6 (21.4)
Pulmonary … 7.1)
Heart disease: 6 (21.4)
IC
Diabetes: 1 (6.3)
Arterial hypertension: 6 (37.5)
Obesity: 3 (18.8)
Pulmonary … Cancer pt: 62 (21) NR Total: 48 (28.9)
HCW: 29 (27.6)
Cancer pt: 19 (31.1) Total
Cardiovascular: 5 (3)
Pulmonary … 5.4)
Diabetes: 6 (3.6)
Autoimmunity: 15 (9)
Hypertension: 19 (11.4)
HCW:
Cardiovascular: 3 (2.9)
Pulmonary … 6.7)
Diabetes: 1 (1)
Autoimmunity: 13 (12.4)
Hypertension: 3 (2.9)
Cancer:
Cardiovascular: 2 (3.3)
Pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
April 20, 2022 - mm Hg or higher17), low platelet count, abnormal liver function, acute abnormal kidney function,
pulmonary … between MgSO4 and specific antihypertensive agents, such as hypotension,
neuromuscular blockade, or pulmonary … mortality, including pregnancy-related mortality*
o Severe maternal morbidity* (e.g., stroke*, eclampsia, pulmonary … mortality, including pregnancy-related mortality*
o Severe maternal morbidity* (e.g., stroke*, eclampsia, pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - Spontaneous reports of pulmonary embolism in association with
raloxifene. … Pulmonary embolism, deep vein thrombosis,
composite measures of coronary heart disease,
myocardial … Composite thromboembolic events, pulmonary
embolism, deep venous thrombosis, cardiovascular
outcomes … Deep venous thrombosis, pulmonary embolism,
concussion, headache, vertigo, abdominal pain,
vaginal … Deep venous thrombosis, pulmonary embolism,
vaginal bleeding, moniliasis, allergy, anxiety,
nervousness
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
September 01, 2011 - The pulmonary edema comments (Results,
page 68-69) are concerning as it is said those studies were likely … underpowered when there were over 1200 cases and the incidence
of pulmonary edema was certainly less … The two studies by Lam et al, under
Pulmonary oedema, were judged as
underpowered not because of the
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper-2015.pdf
January 01, 2015 - Phosphodiesterase 4 inhibitors for chronic
obstructive pulmonary disease. … Tiotropium
versus placebo for chronic obstructive
pulmonary disease. … Inhaled
steroids and risk of pneumonia for chronic
obstructive pulmonary disease. … Integrated disease
management interventions for patients
with chronic obstructive pulmonary
disease … Pulmonary artery catheters
for adult patients in intensive care.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - However, several experts noted that patients will
need to be screened for pulmonary conditions to be … This allows insulin to be absorbed into pulmonary arterial circulation, to achieve
rapid systemic delivery … Afrezza therapy was associated with reduced pulmonary
function that occurred during the first 3 months … Thus, candidates
should undergo pulmonary testing (spirometry [FEV1]) to screen for respiratory conditions … clinical expert stated, “Observational
data suggest potential side effects, such as a decrease in pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cardiology-health-outcomes_research.pdf
July 01, 2010 - Clinical Modification [ICD-9-CM] codes 140-172, 174-195, 200-208, and 238.6),
chronic obstructive pulmonary … — 9808 (14.7) 1280 (17.4)
Cerebrovascular disease — 31 822 (47.7) 4462 (60.6)
Chronic obstructive pulmonary … 0.94 (0.90-0.98)c
Cerebrovascular disease 0.49 (0.48-0.49)b 0.68 (0.65-0.70)b
Chronic obstructive pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
March 01, 2010 - Effectiveness of inhaled
corticosteroids in chronic obstructive
pulmonary disease: immortal time bias … variables by H-ISDN exposure: COMORBIDITY
(Quan 13 modification of Elixhauser 30): Valvular heart disease, Pulmonary … circulation disorders, Paralysis, Other neurologic disorders,
Chronic pulmonary disease, Liver disease
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-237-evidence-summary-palliative-care-ambulatory.pdf
February 01, 2021 - life-threatening chronic illness
or conditions (e.g., advanced heart failure, chronic obstructive pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
December 01, 2023 - (including prepregnancy body mass index, diabetes, hypertension, cardiac disease, renal
disease, pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
September 01, 2011 - Drug
Administration (FDA) has approved terbutaline for the
management of acute and chronic obstructive
pulmonary … of
arrhythmia, heart failure, hyperglycemia,
hypokalemia, maternal mortality, myocardial
infarction, pulmonary … 1.23, 526.6).13 Underpowered studies demonstrated
indeterminate results for the outcomes of mortality,
pulmonary … of
maternal cardiovascular events (hypertension,
myocardial infarction tachycardia, arrhythmias, and
pulmonary … However,
adverse events such as death, hypertension, myocardial
infarction, tachycardia, arrhythmias, and pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
April 01, 2021 - between selective
serotonin reuptake inhibitors and respiratory issues, low Apgar scores, persistent
pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
July 01, 2014 - anomaly
• Other specific adverse events, such as withdrawal
symptoms (neonatal abstinence symptoms),
pulmonary … preterm birth,
small for gestational age, neonatal mortality, congenital
malformations, persistent pulmonary … We found no direct evidence on the risk of neonatal
withdrawal symptoms or pulmonary hypertension with … Indirect evidence suggested
that persistent pulmonary hypertension in the child was
statistically significantly … Antidepressant use
in pregnancy and persistent pulmonary hypertension of the
newborn (PPHN): a systematic
-
effectivehealthcare.ahrq.gov/health-topics/respiratory-failure
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-afib.pdf
November 15, 2018 - unstable angina, or other coronary artery disease; vascular death (e.g., stroke, arterial
embolism, pulmonary … in the supine position, fluid retention; or the description of
rales, jugular venous distention, or pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
September 02, 2016 - [mp=ti, ot, ab, nm, hw, kw, kf, px, rx, ui, an, tx, sh, ct, bt, id, cc]
58. exp pulmonary edema/ … 59. pulmonary edema.mp. … [mp=ti, ot, ab, nm, hw, kw, kf, px, rx, ui, an, tx, sh, ct, bt, id, cc]
60. pulmonary oedema.mp. … coronary/cardiac disease
o peripheral vascular disease (PVD)
o congestive heart failure (CHF)
o pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
January 01, 2011 - diseases that are increasing in prevalence,
including mental disorders, hypertension, heart disease,
pulmonary … , the most
notable increases in recent spending are attributable to
diabetes, chronic obstructive pulmonary